Moving away from chemotherapy in newly diagnosed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia

Br J Haematol. 2023 Sep;202(6):1084-1086. doi: 10.1111/bjh.19012. Epub 2023 Jul 31.

Abstract

Chemotherapy-free regimens are reshaping the treatment landscape of Philadelphia chromosome-positive acute lymphoblastic leukaemia. The report by Xie et al. suggests that the combination of dasatinib and prednisone is effective as induction and early consolidation. Survival was improved in patients who subsequently underwent allogeneic stem cell transplantation. Commentary on: Xie et al. Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial. Br J Haematol 2023;202:1119-1126.

Keywords: blinatumomab; chemotherapy; ponatinib; steroids; tyrosine kinase inhibitor.

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Dasatinib / therapeutic use
  • Humans
  • Philadelphia Chromosome*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Prednisone / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Dasatinib
  • Prednisone
  • Protein Kinase Inhibitors